A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study to Describe the Switching From a First- or Second-line Disease Modifying Therapy (DMT) to Ozanimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Checkpoint Inhibitors and SBRT for MCRPC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Safety and Tolerability of Cendakimab in Chinese Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in Japan
- Status
- COMPLETED
- Phase
- N/A
A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy
- Status
- COMPLETED
- Phase
- N/A
Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Post-Authorization, Long-term Study of Ozanimod Real-world Safety
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy
- Status
- COMPLETED
- Phase
- PHASE3